| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Actinobacteria |
| Bifidobacterium ruminatum (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Methylphenidate |
Click to Show/Hide the Detail |
| Drug ID |
DR1054
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Bifidobacterium ruminatum co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Eggerthella lenta (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Methylphenidate |
Click to Show/Hide the Detail |
| Drug ID |
DR1054
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Eggerthella lenta co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteria: Bacteroidetes |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Bacteroides thetaiotaomicron further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [4] |
| Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Bacteroides uniformis further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [4] |
| Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Bacteroides xylanisolvens co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Bacteria: Firmicutes |
| Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Blautia hansenii co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Methylphenidate |
Click to Show/Hide the Detail |
| Drug ID |
DR1054
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Blautia hansenii co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Methylphenidate |
Click to Show/Hide the Detail |
| Drug ID |
DR1054
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Clostridium botulinum co-metabolize the drug Methylphenidate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Clostridium perfringens (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Clostridium perfringens further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [6] |
| Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Holdemanella biformis co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [2] |
| Lactococcus lactis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Enalapril |
Click to Show/Hide the Detail |
| Drug ID |
DR0573
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Lactococcus lactis co-metabolize the drug Enalapril, which can collectively affect efficacy, safety or bioavailability of this drug. |
[5], [7] |
| Streptococcus agalactiae (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Streptococcus agalactiae further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [6] |
| Bacteria: Proteobacteria |
| Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) metabolizes the drug Irinotecan hydrochloride, and Escherichia coli further metabolizes its metabolite (SN-38G), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
| Irinotecan hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0881
Drug Info
|
| Interaction Mechanism |
Human Carboxylesterase 1 (CES1) and Escherichia coli co-metabolize the drug Irinotecan hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
|
|
|
|
|
|